Abstract
Prostate-specific membrane antigen antibody–drug conjugate (PSMA ADC): A phase I trial in taxane-refractory prostate cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1200/jco.2011.29.15_suppl.4650
Journal: Journal of Clinical Oncology | Publication Date: May 20, 2011 |
Citations: 3 |
Prostate-specific membrane antigen antibody–drug conjugate (PSMA ADC): A phase I trial in taxane-refractory prostate cancer.
Join us for a 30 min session where you can share your feedback and ask us any queries you have